Fisher Technology Revenue and Competitors

Miami, FL USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Fisher Technology's estimated annual revenue is currently $652.5k per year.(i)
  • Fisher Technology's estimated revenue per employee is $72,500

Employee Data

  • Fisher Technology has 9 Employees.(i)

Fisher Technology's People

NameTitleEmail/Phone
1
Director OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2720.7M84607%N/AN/A
#2
$9.1M72-3%$15.2MN/A
#3
$105M5701%$138.7MN/A
#4
$12.9M89N/AN/AN/A
#5
$90.6M4920%$48MN/A
#6
$2.7M27N/AN/AN/A
#7
$0.4M12-8%$3.4MN/A
#8
$13.8M95-22%$64.5MN/A
#9
$2.7M27N/AN/AN/A
#10
$10.4M67N/AN/AN/A
#11
$0.5M14-22%$41.5MN/A
#12
$0M1-93%$5.5MN/A
#13
$113.1M63621%$229.6M$400M
#14
$14.8M102-12%$7.5MN/A
#15
$1M11N/AN/AN/A
#16
$29.3M184N/AN/AN/A
#17
$25.4M159N/AN/AN/A
#18
$2.6M26N/AN/AN/A
#19
$22.2M1098%N/AN/A
#20
$15.8M109N/AN/AN/A
Add Company

What Is Fisher Technology?

keywords:N/A

N/A

Total Funding

9

Number of Employees

$652.5k

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Fisher Technology News

2022-04-17 - Global CRISPR Technology Market Analysis 2022-2026, Featuring Profiles of Thermo Fisher Scientific, CRISPR Therapeutics, GenScript Biotech, Editas Medicine and Intellia Therapeutics

Global CRISPR Technology Market Analysis 2022-2026, Featuring Profiles of Thermo Fisher Scientific, CRISPR Therapeutics, GenScript Biotech,...

2022-04-17 - Thermo Fisher opens bioprocessing manufacturing facility in ...

Ogden — Thermo Fisher Scientific recently celebrated the opening of its new single-use technology manufacturing site in Ogden, Utah.

2022-04-17 - Unlearn.AI, a startup developing a ‘digital twin’ service for clinical trials, raises $50M

“The clinical trial technology industry has one major problem: Pharma companies are skeptical of new technology,” Fisher said. “The big...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.7M9N/AN/A
#2
$0.7M929%N/A
#3
$0.7M9-53%N/A
#4
$0.3M913%N/A
#5
$0.9M913%N/A